7 completed, 3 terminated, 3 unknown. 13 Phase 2, 5 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 7, Terminated 3, Unknown 3 |
| Phase 3 | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow VSL#3: new trials by email Literature Review of VSL#3 trials Research Report on VSL#3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maternal Probiotic Intervention to Improve Gut Health Vivomixx, CapScanĀ® - Environmental Enteric Dysfunction, Stunting | Phase 2 | Completed | Aga Khan University | 76 | 2023-08-09 | 2025-07-16 |
| Ability of the Probiotic Vivomixx to Improve Environmental Enteropathy in Pregnant Women: a Proof of Concept Trial in Bangladesh, Pakistan, Senegal and Zambia VSL#3, Capscan device, Placebo - Environmental Enteropathy | Phase 2 | Unknown | Tropical Gastroenterology & Nutrition Group (TROPGAN) | 76 | 2022-12-01 | 2022-11-08 |
| Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women VSL#3, Placebo - Menopausal Osteoporosis | Phase 2 | Terminated | Emory University | 35 | 2017-10-01 | 2020-03-04 |
| Probiotic (Visbiome) for Gulf War Illness Placebo, Visbiome, VSL#3 - Gulf War Illness | Phase 2 / Phase 3 | Unknown | Ashok Tuteja | 60 | 2013-09-13 | 2017-12-13 |
| Probiotic (VSL #3) for Gulf War Illness VSL#3, Placebo - Gulf War Illness | Phase 2 / Phase 3 | Terminated | University of Utah | 29 | 2013-09-01 | 2018-10-26 |
| Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation VSL#3, Placebo - Hepatic Encephalopathy | Phase 2 / Phase 3 | Completed | CD Pharma India Pvt. Ltd. | 130 | 2010-04-01 | 2013-12-30 |
| Probiotics for the Prevention of Antibiotics Associated Diarrhoea and Clostridium Difficile Associated Diarrhoea VSL#3, Placebo - Diarrhoea | Phase 2 / Phase 3 | Completed | National Health Service, United Kingdom | 231 | 2010-04-01 | 2013-04-26 |
| The Effect of Probiotics (VSL) on Portal Hypertension Probiotic - Portal Hypertension | Phase 1 / Phase 2 | Completed | University of Alberta | 18 | 2009-12-01 | 2012-01-20 |
| Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life VSL#3, Lactulose - Chronic Liver Disease, Hepatic Encephalopathy | Phase 2 / Phase 3 | Completed | CD Pharma India Pvt. Ltd. | 120 | 2009-10-01 | 2013-06-04 |
| A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE VSL#3, sugar pill (placebo) - Anti-biotic Resistance | Phase 2 | Completed | University of Wisconsin, Madison | 90 | 2008-10-01 | 2015-10-08 |
| Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia VSL#3, Polyethylene glycol - Anti-Biotic Resistance, Klebsiella Pneumoniae | Phase 1 / Phase 2 | Unknown | Hadassah Medical Organization | 60 | 2008-09-01 | 2008-07-25 |
| Safety of VSL#3 in Adult Asthmatics VSL#3, VSL#3 or placebo - Asthma | Phase 1 / Phase 2 | Terminated | University of Maryland, Baltimore | 3 | 2007-02-01 | 2023-04-20 |
| Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC) VSL#3, Placebo - Hirschsprung Disease | Phase 2 | Completed | University of Michigan | 62 | 2006-09-01 | 2016-07-19 |
Hepatic Encephalopathy (2) · Irritable Bowel Syndrome (2) · Asthma (1) · Diarrhea (1) · End Stage Liver Disease (1) · Enterocolitis (1) · Fibrosis (1) · Growth Disorders (1) · Hirschsprung Disease (1) · Hypertension, Portal (1) · Infections (1) · Osteoporosis, Postmenopausal (1)
CD Pharma India Pvt. Ltd. (2) · Aga Khan University (1) · Ashok Tuteja (1) · Emory University (1) · Hadassah Medical Organization (1) · National Health Service, United Kingdom (1) · Tropical Gastroenterology & Nutrition Group (TROPGAN) (1) · University of Alberta (1) · University of Maryland, Baltimore (1) · University of Michigan (1) · University of Utah (1) · University of Wisconsin, Madison (1)
United States (6) · India (2) · Pakistan (2) · Bangladesh (1) · Canada (1) · Israel (1) · Senegal (1) · United Kingdom (1) · Zambia (1)
Alessio Fasano, M. D. (1) · Asad Ali, Dr (1) · Asad Ali, MPH (1) · Ashok Tuteja, MD, MPH (1) · Daniel H Teitelbaum, MD (1) · Fyezah Jehan, Dr (1) · Maya Margalit, MD (1) · Nasia Safdar, MD, MS (1) · Neil Haslam (1) · Paul Kelly, Dr (1) · Puneeta Tandon, MD, FRCPC, MSc (1) · Radha K Dhiman, MD,DM,MNAMS (1) · Roberto Pacifici (1) · Tahmeed Ahmed, Dr (1) · Vince Bain, MD, FRCPC (1)
PMID 23331802, PMID 23618760, PMID 25450083, PMID 27187907, PMID 31325468, PMID 34712928
R21AT004089 (1)